Nidda Healthcare Holding, founded in 2014 and based in Frankfurt, Germany, is focused on providing innovative healthcare solutions, primarily within the pharmaceutical and medical device sectors. The company aims to enhance patient outcomes through the development and distribution of specialized medical products and services.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| SAZGR 7.50% 2026-08-21 EURNidda Healthcare Holding | Germany | 2026-08-21 | 7.500 | 5.19 |
| SAZGR 7.50% 2026-08-21 EURNidda Healthcare Holding | Germany | 2026-08-21 | 7.500 | 5.62 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Nidda Healthcare has actively engaged in the bond market since 2018, with significant issuances aimed at financing its growth initiatives and research endeavors. Noteworthy was the €300 million bond issued in 2021, which featured a competitive yield of 3.5%, notably lower than the industry average at the time. The bond's success further solidified Nidda's reputation among investors, providing essential capital for strategic acquisitions and expansions while enhancing liquidity as the company continues to innovate.